Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Cianferani

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Mabs|December 27, 2019
Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assemblyMercè Farràs, Joan Miret, Marc Camps, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 28, 2021
Fast Afucosylation Profiling of Glycoengineered Antibody Subunits by Middle-Up Mass SpectrometryElsa Wagner-Rousset, Olivier Colas, Stéphane Chenu, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 1, 2020
Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificitiesElsa Wagner, Olivier Colas, Stéphane Chenu, et al.
Scientific Reports|August 3, 2021
Catestatin in innate immunity and Cateslytin-derived peptides against superbugsFrancesco Scavello, Angela Mutschler, Sophie Hellé, et al.
Analytical Chemistry|May 15, 2020
Glycan-Mediated Technology for Obtaining Homogeneous Site-Specific Conjugated Antibody-Drug Conjugates: Synthesis and Analytical Characterization by Using Complementary Middle-up LC/HRMS AnalysisBastiaan L Duivelshof, Evolène Deslignière, Oscar Hernandez-Alba, et al.
Oncotarget|August 20, 2016
MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox stateFrédéric Frottin, Willy V Bienvenut, Jérôme Bignon, et al.
Science Advances|February 1, 2021
Rab7-harboring vesicles are carriers of the transferrin receptor through the biosynthetic secretory pathwayMaika S Deffieu, Ieva Cesonyte, François Delalande, et al.
Analytical Chemistry|December 21, 2017
An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug ConjugatesAnthony Ehkirch, Valentina D'Atri, Florent Rouviere, et al.
Bioconjugate Chemistry|September 15, 2022
A Novel Family of Acid-Cleavable Linker Based on Cyclic Acetal Motifs for the Production of Antibody-Drug Conjugates with High Potency and SelectivityTony Rady, Lorenzo Turelli, Marc Nothisen, et al.
Analytical Chemistry|November 27, 2024
Therapeutic Monoclonal Antibody─Antidrug Antibody Affinity Constant Determination Using Capillary Electrophoresis-Tandem Mass SpectrometryTessa Reinert, Pascal Houzé, Nathalie Mignet, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Mabs|December 27, 2019
Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assemblyMercè Farràs, Joan Miret, Marc Camps, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 28, 2021
Fast Afucosylation Profiling of Glycoengineered Antibody Subunits by Middle-Up Mass SpectrometryElsa Wagner-Rousset, Olivier Colas, Stéphane Chenu, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 1, 2020
Determination of size variants by CE-SDS for approved therapeutic antibodies: Key implications of subclasses and light chain specificitiesElsa Wagner, Olivier Colas, Stéphane Chenu, et al.
Scientific Reports|August 3, 2021
Catestatin in innate immunity and Cateslytin-derived peptides against superbugsFrancesco Scavello, Angela Mutschler, Sophie Hellé, et al.
Analytical Chemistry|May 15, 2020
Glycan-Mediated Technology for Obtaining Homogeneous Site-Specific Conjugated Antibody-Drug Conjugates: Synthesis and Analytical Characterization by Using Complementary Middle-up LC/HRMS AnalysisBastiaan L Duivelshof, Evolène Deslignière, Oscar Hernandez-Alba, et al.
Oncotarget|August 20, 2016
MetAP1 and MetAP2 drive cell selectivity for a potent anti-cancer agent in synergy, by controlling glutathione redox stateFrédéric Frottin, Willy V Bienvenut, Jérôme Bignon, et al.
Science Advances|February 1, 2021
Rab7-harboring vesicles are carriers of the transferrin receptor through the biosynthetic secretory pathwayMaika S Deffieu, Ieva Cesonyte, François Delalande, et al.
Analytical Chemistry|December 21, 2017
An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug ConjugatesAnthony Ehkirch, Valentina D'Atri, Florent Rouviere, et al.
Bioconjugate Chemistry|September 15, 2022
A Novel Family of Acid-Cleavable Linker Based on Cyclic Acetal Motifs for the Production of Antibody-Drug Conjugates with High Potency and SelectivityTony Rady, Lorenzo Turelli, Marc Nothisen, et al.
Analytical Chemistry|November 27, 2024
Therapeutic Monoclonal Antibody─Antidrug Antibody Affinity Constant Determination Using Capillary Electrophoresis-Tandem Mass SpectrometryTessa Reinert, Pascal Houzé, Nathalie Mignet, et al.
Pageof 5